• No se han encontrado resultados

PUBLICACIONES de los últimos 5 años SERVICIO DE CARDIOLOGÍA

N/A
N/A
Protected

Academic year: 2022

Share "PUBLICACIONES de los últimos 5 años SERVICIO DE CARDIOLOGÍA"

Copied!
13
0
0

Texto completo

(1)

PUBLICACIONES de los últimos 5 años

SERVICIO DE CARDIOLOGÍA

1. De la Torre Hernández JM, Gorria GM, Vázquez de Prada JA, Zueco J. Papillary muscle rupture: First report of this complication in a retrograde transfemoral aortic valve implantation. Catheter Cardiovasc Interv. 2011;78(4):647-9.

2. Pablo Salinas, Guillermo Galeote, Roberto Martín-Reyes, María J. Pérez-Vizcayno, Rosana Hernández-Antolín, Vicente Mainar, José Moreu, José M. de la Torre, Javier Zueco, et al. Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry. Eurointervention 2011;6:1-5.

3. Villar AV, Merino D, Wenner M, Llano M, Cobo M, Montalvo C, García R, Martín-Durán R, Hurlé JM, Hurlé MA, Nistal JF. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjuction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis.

Heart. 2011 Jul;97(14):1132-7.

4. Durst R, Avelar E, McCarty D, Poh KK, Friera LF, Llano MF, Chu J, Anumandla AK, Rodriguez LL, Mack MJ, Hanzel G, Kodali SK, Hung J, Picard MH. Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. J Heart Valve Dis. 2011 May;20(3):272-81.

5. Gonzalez-Vílchez F, Vázquez de Prada J.A., Canteli A., Castrillo C., Llano M., Martín Duran R. Predictors of Long Term Renal Function after Conversion to Proliferation Signal Inhibitors in Long-Term Heart Transplant Recipients. J Heart Lung Transplant.

2011 May;30(5):552-7.

6. de la Torre Hernández JM, Hernández Hernández F, Alfonso F, Rumoroso JR, López- Palop R, Sadaba M, Carrillo P, Rondán J, Lozano I, Ruiz Nodar JM, Baz JA, Fernandez Nofrerias E, Pajín F, García Camarero T, Gutierrez H; LITRO Study Group (Spanish Working Group on Interventional Cardiology). Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol. 2011 Jul 19;58(4):351-8.

7. M.G. Crespo-Leiro, A. Villa-Arranz, N. Manito-Lorite, M.J. Paniagua-Martín, G. Rábago, L. Almenar-Bonete, L. Alonso-Pulpón, S. Mirabet-Pérez, B. Díaz-Molina, F. González- Vílchez, J.M. Arizón de Prado, N. Romero-Rodríguez, J. Delgado-Jiménez, E. Roig, T.

Blasco-Peiró, D. Pascual-Figal, L. De la Fuente Galán, J. Muñíz. Lung cancer after heart transplantation: Results from a large multicenter Registry. Am J Transplant. 2011; 11:

1035-1040.

8. González-Vílchez F, Vázquez de Prada JA. The role of pre-conversion glomerular filtration rate in predicting long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients. J Heart Lung Transplantation 2011; 30:

1302. (letter).

(2)

9. Lozano I, Cuellas C, Avanzas P, de Prado AP, Suárez C, Rondán J, Lee D, de la Hera JM, Fernández F, Morís C. Cobalt-Chromium Stents in Long Lesions of Large Vessels.

Clnical and Angiographic Results. Tex Heart Inst J. 2011; 38: 35-41.

10. Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, Cobo M, Delgado J;

Equipos Españoles de Trasplante Cardiaco. Registro Español de Trasplante Cardiaco.

XXII Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2010). Rev Esp Cardiol. 2011 Dec;64(12):1138-46.

11. José M. de la Torre Hernández, José F. Díaz Fernández, Manel Sabate Tenas y Javier Goicolea Ruigómez. Actualización en cardiología intervencionista. Rev Esp Cardiol.2011; 64(Supl.1) :13-9.

12. Díaz JF, de la Torre JM, Sabaté M, Goicolea J. Spanish cardiac catheterization and coronary intervention registry. 20th official report of the spanish society of cardiology working group on cardiac catheterization and interventional cardiology (1990-2010)].

Rev Esp Cardiol. 2011 Nov;64(11):1012-22.

13. Expósito V, Rodríguez-Entem F, González-Enríquez S, Olalla J. Droneradone for recurrent ventricular tachycardia: a real alternative?. Indian Pacing Electrophysiol J 2012; Mar, 12(2): 73-6.

14. S. González-Enríquez, F. Rodríguez-Entem, V. Expósito, C. Castrillo-Bustamante, A.

Canteli, A. Solloso, I. Madrazo, J. J. Olalla. Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better?. JICE 2012;35:343- 349.

15. Villar AV, Merino D, Wenner M, Llano M, Cobo M, Montalvo C, García R, Martín-Durán R, Hurlé JM, Hurlé MA, Nistal JF. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis.

Heart. 2011 Jul;97(14):1132-7 doi:10.1136/ hrt.2010.220418.

16. Montalvo C, Villar AV, Merino D, García R, Ares M, Llano M, Cobo M, Hurlé MA, Nistal JF. Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β”. PlosOne. En prensa. DOI:

10.1371/journal.pone.0035635.

17. Villar AV, García R, Merino D, Llano M, Cobo M, Montalvo C, Martín Durán M, Hurlé MA, Nistal JF. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol (2012), http://dx.doi.org/10.1016/j.ijcard.2012.07.021.

18. Yared K, Garcia-Camarero T, Fernandez-Friera L, Llano M , Durst R, Reddy A.A, O’Neill W.W, Picard M. H. Impact of Aortic Regurgitation After Transcatheter Aortic Valve Implantation. Results From the REVIVAL Trial. JACC: Cardiovascular Imaging 2012;

5(5): 469-477.

19. Francisco González-Vílchez, José Antonio Vázquez de Prada, Luis Almenar, José María Arizón del Prado, Sonia Mirabet, Beatriz Díaz-Molina, Juan Francisco Delgado, Manuel Gómez-Bueno, María Jesús Paniagua, Félix Pérez-Villa, Eulalia Roig, Luis Martínez- Dolz, Vicens Brossa, José Luis Lambert, Javier Segovia, María Generosa Crespo-Leiro, María Jesús Ruiz-Cano. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation. J Heart Lung Transplat. 2012;

31: 288-295.

(3)

20. Paniagua Martín MJ, Almenar L, Brossa V, Crespo-Leiro MG, Segovia J, Palomo J, Delgado J, González-Vílchez F, Manito N, Lage E, García-Guereta L, Rodríguez- Lambert JL, Albert DC. Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry. Clin Transplant. 2012; 26: 755- 763.

21. Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, González-Vílchez F, Almenar L, et al. Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency. Am J Transplant 2012; 12 (9): 2487-2497.

22. Crespo Leiro MG, Bonet LA, Paniagua Martín MJ, Gómez Bueno M, Escribano P, González Vílchez F, Rodríguez Lambert JL, Brossa Loidi V, Lage Gallé E, Delgado Jiménez J. Steroid withdrawal during 5 years following heart transplantation and the relationship between steroid dosage at 1-year follow-up and complications during the next 2 years: results from the RESTCO study. Transplant Proc. 2012; 44: 2631-4.

23. Val-Bernal JF, Neira C, Nistal JF, González-Vílchez FJ, González-Gay JM, Val D.

Simultaneous papillary fibroelastomas of the pulmonary and aortic valves. Pathol Res Pract. 2012; 208: 315-317.

24. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernández JM, et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2012 Feb 21. [Epub ahead of print].

25. Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martín E, Serra A, Rumoroso JR, Ruiz-Salmerón R, de la Torre JM, Cequier A, Gómez-Hospital JA, Alfonso F, Martín-Yuste V, Sabatè M, García-Dorado D. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9.

26. Ibañez B, Fuster V, Macaya C, Sánchez-Brunete V, Pizarro G, López-Romero P, Mateos A, Jiménez-Borreguero J, Fernández-Ortiz A, Sanz G, Fernández-Friera L, Corral E, Barreiro MV, Ruiz-Mateos B, Goicolea J, Hernández-Antolín R, Acebal C, García-Rubira JC, Albarrán A, Zamorano JL, Casado I, Valenciano J, Fernández-Vázquez F, de la Torre JM, Pérez de Prado A, Iglesias-Vázquez JA, Martínez-Tenorio P, Iñiguez A. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer- blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. Am Heart J. 2012 Oct;164(4):473-480.

27. Fernández-Valls M., Arnaíz J. Canga A., M-Durán R. Images in Cardiology. Double aortic arch presents with dysphagia as initial symptom. JACC Vol.60 Issue 12 p.1114 Sept.2012 .

28. Anguita M, Comín J, Almenar L, Crespo M, Delgado J, González-Costello J, Hernández- Madrid A, Manito N, Pérez de la Sota E, Segovia J, Segura C, Alonso-Gómez AM, Anguita M, Cequier A, Comín J, Díaz-Buschmann I, Fernández-Lozano I, Fernández- Ortiz A, Gómez de Diego JJ, Pan M, Worner F, Alonso-Pulpón L, Bover R, Castro A, Díaz-Molina B, Gómez-Bueno M, González-Juanatey JR, Lage E, López-Granados A, Lupón J, Martínez-Dolz L, Muñoz R, Pascual D, Ridocci F, Roig E, Varela A, Vázquez de Prada JA. Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed).

2012;65:874-8.

(4)

29. Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, González-Vílchez F, et al. Registro Español de Trasplante Cardiaco. XXIII Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2011). Rev Esp Cardiol. 2012; 65: 1030-1038.

30. José M. de la Torre Hernández, José F. Díaz Fernández, Manel Sabate Tenas y Javier Goicolea Ruigómez. Actualización en cardiología intervencionista. Rev Esp Cardiol.2012; 65(Supl.1) :4-11.

31. José M. de la Torre Hernández, Stephan Windecker. Trombosis muy tardía con nuevos stents farmacoactivos: ¿ha dejado de ser un asunto relevante?. Rev Esp Cardiol.

2012;65:595-8.

32. Díaz JF, de La Torre JM, Sabaté M, Goicolea J. Spanish Cardiac Catheterization and Coronary Intervention Registry. 21st official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2011).

Rev Esp Cardiol. 2012 Dec;65(12):1106-16.

33. Rabanal Llevot, J.M.; Cimadevilla Calvo, B.; Cifrián Martínez, J.M.; Ruisánchez Villar, C.; Mons Lera, R Efecto de iloprost nebulizado combinado con óxido nítrico inhalado y sildenafilo oral en las presiones pulmonares de pacientes sometidos a trasplante pulmonar. Eficacia terapéutica en la hipertensión pulmonar intraoperatoria. Rev Esp Anestesiol Reanim.2012; 59 :142-9 - vol. 59 núm 03 CLAVE A.

34. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2013 Jul 31;167(2):575-84.

35. De la Torre Hernández JM, Alfonso F, Recalde AS, Jiménez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, Camarero TG, Elizaga J, Rivero F, Gimeno F, Calviño R, Moreu J, Bosa F, Rumoroso JR, Bullones JA, Gallardo A, Fernández Díaz JA, Ruíz Arroyo JR, Aragón V, Masotti M; ESTROFA-LM Study Group. Comparison of Paclitaxel-Eluting Stents (Taxus) and Everolimus-Eluting Stents (Xience) in Left Main Coronary Artery Disease With 3 Years Follow-Up (from the ESTROFA-LM Registry). Am J Cardiol. 2013 Mar 1;111(5):676-83.

36. Cascón-Pérez JD, de la Torre-Hernández JM, Ruiz-Abellón MC, Martínez-Pascual M, Mármol-Lozano R, López-Candel J, Cano P, Fernández C, Ramos JL, Villegas M, Picó- Aracil F. Characteristics of culprit atheromatous plaques obtained in vivo by intravascular ultrasound radiofrequency analysis: results from the CULPLAC study. Am Heart J. 2013 Mar;165(3):400-7.

37. José M. de la Torre Hernández, MD, PhD, Tamara García Camarero, MD, Piedad Lerena, MD, Dae-Hyun Lee, MD, Fermín Saínz Laso, MD, Gonzalo Martín Gorria, MD, Javier Zueco, MD. A real all-comers randomized trial comparing xience prime and promus element stents. J Invasive Cardiol. 2013 ;25:182-5.

38. de la Torre Hernández JM, López-Palop R, Garcia Camarero T, Carrillo Sáez P, Martin Gorria G, Frutos Garcia A, Arnáez Corada B, Cordero Fort A, Gómez Delgado JM, Agudo Quilez P, Lee DH, Mateo Rodríguez I, Saínz Laso F, Khashaba A, Miralles Arques S, Zueco Gil J. Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach. EuroIntervention. 2013 Nov 22;9(7):824-30.

(5)

39. De la Torre Hernández JM, Lee DH, García-Camarero T, Saínz Laso F, Zueco J.

Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography. EuroIntervention. 2013 Dec 23;9(8):952-8.

40. Ibañez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodríguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García- Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández- Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Effect of Early Metoprolol on Infarct Size in ST-Segment-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial.

Circulation. 2013 Oct 1;128(14):1495-1503. Epub 2013 Sep 3.

41. Felipe J. Rodríguez-Entem, Víctor Expósito, Susana González-Enríquez, Juan José Olalla-Antolín. Cryoablation versus radiofrequency ablation for the treatment of atrioventricular nodal reentrant tachycardia: results of a prospective randomized study.

JICE 2013; 36:41–45.

42. Expósito V, Guzmán JC, Orava M, Armaganijan L, Morillo CA. Usefulness of Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly.

Europace 2013; Aug;15(8):1210-4.

43. Expósito V, González-Enríquez S, Hevia N, Rodríguez-Entem F, Arnáez B, Olalla JJ.

Sensado de miopotenciales en paciente portador de DAI: ¿Cuál es el mecanismo?.

Revista Iberoamericana Arritmología, 2013. Jun 13 Vol. 4 No. 1, 35-9.

44. Lacunza FJ, Moya A, Martínez-Alday J, Barón G, Ruiz Granell R, Rivas N, González- Enríquez S, Leal J, Arcocha MF, Pérez Villacastín J, García Heil N, García-Arberola A.

Implantable loop recorder allows an etiologic diagnosis in one third patients. Results of the Spanish Reveal Registry. Circ J 2013; 77(10); 2535-41.

45. Afilalo J, Flynn AW, Shymony A, Rudski LG, Agnihotri AK, Morin JF, Castrillo C, Shahian DM, Picard MH. “Incremental value of the preoperative echocardiogram to predict mortality and major morbidity in coronary artery bypass surgery”. Circulation 2013 Jan 22;127(3):356-64.

46. Flynn AW, Afilalo J, Agnihotri AK, Castrillo C, Shahian DM, Picard MH. “Aortic sclerosis is associated with mortality and major morbidity in patients undergoing coronary artery bypass surgery”. Heart 2013 Feb;99(4):247-52.

47. García R, Villar A, Cobo M, Llano M, Martín Durán R, Hurle M, Nistal JF. “Circulating levels of mi-R133a predict the regression potential of the left ventricular hypertrophy after valve replacement in patients with aortic stenosis. J Am Heart Assoc.

2013;2:e000211doi:10.1161/JAHA.113.000211.

48. Villar A, García R, Llano M, Cobo M, Merino D, Lantero A, Tramullas M, Hurle JM, Hurle M, Nistal JF. “BMP and activein membrane bound inhibitor protects the murine heart from pressure overload biomechanical stress by restraining TGF-ß signaling”.

Biochimica et Biophysica Acta 1832. 2013: 323-335.

49. Villar A, García R, Merino D, Llano M, Cobo M, Montalvo C, Martín Durán R, Hurle M, Nistal JF. “Myocardial and circulating levels of microRNA21 reflect left ventricular fibrosis in aortic stenosis patients”. Int J Cardiol. 2013 Sep 10;167(6):2875-81.

(6)

50. Zimbarra Cabrita I, Ruísanchez C, Grapsa J, Dawson D, North B, Pinto FJ, Gibbs JS, Nihoyannopoulos P. Validation of the isovolumetric relaxation time for the estimation of pulmonary systolic arterial blood pressure in chronic pulmonary hypertension. Eur Heart J Cardiovasc Imaging. 2013 Jan;14(1):51-5. doi: 10.1093/ehjci/jes093. Epub 2012 May 15. PubMed PMID: 22588209.

51. Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, Gonzalez-Vílchez F, Villa- Arranz A, Delgado-Jiménez J, Lage-Galle E, Pérez-Villa F, Lambert-Rodríguez JL, Manito-Lorite N, Arizon-Del Prado JM, Brossa-Loidi V, Pascual-Figal D, Fuente-Galán L, Sanz-Julve M, Muñiz-Garcia J, Crespo-Leiro M. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail. 2013 Jul;6(4):763-72. doi: 10.1161/CIRCHEARTFAILURE.112.000237. Epub 2013 May 14.

52. Cosío Carmena MD, Gómez Bueno M, Almenar L, Delgado JF, Arizón JM, González Vílchez F, Crespo-Leiro MG, Mirabet S, Roig E, Pérez Villa F, Fernández-Yañez JF, Lambert JL, Manito N, Fuente L, Sanz Julve ML, Pascual D, Rábago G, Millán I, Alonso- Pulpón LA, Segovia. Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score. J. Heart Lung Transplant. 2013 Dec;32(12):1187-95. doi: 10.1016/j.healun.2013.08.004.

53. González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Gómez-Bueno M, Arizón JM, Almenar L, Roig E, Delgado J, Lambert JL, Pérez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, López-Granados A, Martínez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23.

54. González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation. Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241.

Epub 2013 Sep 12.

55. Solís J, Piro V, Loughlin G, Vázquez de Prada JA. How to grade mitral regurgitation: an integrative approach. Cardiol Clin. 2013 May;31(2):169-75. doi:

10.1016/j.ccl.2013.04.002. Review.

56. Solis J, Piro V, Vázquez de Prada JA, Loughlin G. Echocardiographic assessment of mitral regurgitation: general considerations. Cardiol Clin. 2013 May;31(2):165-8. doi:

10.1016/j.ccl.2013.04.001. Review.

57. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED- HF Committees; RED-HF Investigators. ( Berrazueta Fernández JR, Principal investigator H. Valdecilla, Santander Spain).Treatment of anemia with darbapoetin alfa in systolic heart failure. N Engl J Med. 2013;368:1210-9. doi: 10.1056/NEJM.

58. McMurray JJ, Anand IS, Díaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators ( Berrazueta Fernández JR, Principal investigator H. Valdecilla, Santander Spain). Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail.

2013;15:334-41.

(7)

59. José M. de la Torre Hernández, José F. Díaz Fernández, Manel Sabate Tenas y Javier Goicolea Ruigómez. Actualización en cardiología intervencionista. Rev Esp Cardiol.

2013;66:282-9.

60. Rodríguez Entem F, González Enríquez S, Expósito V, Olalla JJ. La Unidad de Sincope.

Cuadernos de Estimulación Cardíaca. 2013; 103-110.

61. Fradejas Sastre V, Pérez Velasco P. Importancia de una comunidad educativa formada en técnicas de reanimación cardiopulmonar. Cuidados Intensivos Cardiológicos. Nuber Científ. 2013;2(10): 13-17.

62. González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Martínez-Sellés M, Delgado J, Roig E, Lage E, Manito N. Registro Español de Trasplante Cardiaco. 24.

63. Informe Oficial de la Sociedad Española de Cardiología en Insuficiencia Cardiaca y Trasplante Cardiaco (1984-2012). Rev Esp Cardiol. 2013; 66:973-982 FI:.. 3204 [doi:

10.1016/j.recesp.2013.08.004].

64. Barge Caballero, E., Segovia-Cubero, J., Almenar Bonet, L., González-Vílchez, F., Villa- Arranz, A., Delgado-Jiménez, J., Lage-Galle, E. Pérez-Villa , F. Lambert-Rodríguez, JL, Crespo-Leiro, M. Emergencia cardiaca nuevo trasplante: ¿se justifica? Los datos del registro de trasplante cardíaco Nacional. Eur Heart J. 2013; 34:946-946.

65. Rábago, G., Almenar, L. Fernández-Vanez, J., Lage, E., Lambert, JL González-Vílchez, F. Crespo-Leiro, MG, Delgado, JF. Observacional Estudio Epidemiológico para evaluar el riesgo cardiovascular Factores en receptores de trasplantes de corazón en España (CTC Study): Resultados preliminares a los 18 meses después del trasplante. Transplante J Heart Lung. 2013; 32:205-206.

66. Coordinadores:, Worner F, Cequier A; Grupo de Trabajo de la Sociedad Española de Cardiología para la guía de práctica clínica sobre el síndrome coronario agudo con elevación del segmento ST:, Bardají A, Bodí V, Bover R, Martínez-Sellés M, Sabaté M, Sionis A, Vázquez de Prada JA; Grupo de Revisores Expertos para la guía de síndrome coronario agudo con elevación del segmento ST:, Arós F, Arribas F, Barrabés J, Díaz de Castro O, Heras M, López Palop R, López-Sendón JL, Manito N, de Pablo MC, Ripoll T, San Román A, de la Torre JM; Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología:, Fernández-Ortiz A, Alonso Gómez AM, Anguita M, Cequier A, Comín J, Díaz-Buschmann I, Fernández Lozano I, Gómez de Diego JJ, Pan M, Worner F. Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation. Rev Esp Cardiol. 2013 Jan;66(1):5- 11. doi: 10.1016/j.recesp.2012.10.013. Epub 2012 Dec 25. English, Spanish. No abstract available. Erratum in: Rev Esp Cardiol. 2013 Apr;66(4):329. Vázquez de Prada, Manuel [corrected to Vázquez de Prada, José Antonio].

67. De Belder A, de la Torre Hernandez JM, Lopez-Palop R, O'Kane P, Hernandez F, Strange J, Gimeno F, Cotton J, Diaz Fernandez J, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz J, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D. A Prospective Randomized Trial Of Everolimus-Eluting Stents Versus Bare Metal Stents In Octogenarians: Xience Or Vision Stents For The Management Of Angina In The Elderly - The Xima Trial. J Am Coll Cardiol. 2014; 63: 1371-5.

CONTINÚA EN SIGUIENTE PÁGINA

(8)

68. Jose M de la Torre Hernandez, José Antonio Baz Alonso, Joan Antoni Gómez Hospital, Fernando Alfonso, Tamara Garcia Camarero, Federico Gimeno de Carlos, Gerard Roura Ferrer, Angel Sanchez Recalde, Íñigo Lozano Martínez-Luengas, Josep Gomez Lara, Felipe Hernandez, María José Pérez-Vizcayno, Angel Cequier Fillat, Armando Perez de Prado, Agustín Albarrán, Manuel Jimenez Navarro, Josepa Mauri, Jose A Fernandez Diaz, Eduardo Pinar, Javier Zueco. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: patient level pooled analysis of 4 registries. J Am Coll Cardiol Intv. 2014;7:244-54.

69. Valgimigli M, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Ferrante G. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ. 2014 Nov 4;349:g6427.

70. Dominguez-Rodriguez A, Abreu-Gonzalez P, Del Mar Garcia-Saiz M, Aldea-Perona A, de la Torre JM, Garcia-Camarero T, Consuegra-Sanchez L; on behalf of the MARIA Study Investigators. Cardioprotection with melatonin in the acute myocardial infarction:

Awaiting results of MARIA trial ?. Int J Cardiol. 2014 Dec 30;182C:54-55.

71. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster VResponse to letter regarding article,

"effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".

Circulation. 2014 Jul 15;130(3):e19-20.

72. De la Torre Hernandez JM, Masotti Centol M, Lerena Saenz P, Sánchez Recalde A, Gimeno de Carlos F, Piñón Esteban P, Fernandez Rodriguez D, Sitges Carreño M, Sabate Tenas M, Zueco Gil J. Eficacia y seguridad a más de 10 años de la ablación septal percutánea en la miocardiopatía hipertrófica obstructiva. Rev Esp Cardiol.

2014;67:353-8.

73. De la Torre Hernández JM, Alfonso F, Martin Yuste V, Sánchez Recalde A, Jiménez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, García Camarero T, Elizaga J, Calviño R, Moreu J, Bosa F, Jimenez Mazuecos J, Ruiz-Arroyo JR, García Del Blanco B, Rumoroso JR; en representación del grupo de estudio ESTROFA-IM. Comparacion de stents de Paclitaxol y stents de everolimus enel infartocon elevaciond el ST e influencia de la trombectomia en los resultados. Estudio ESTROFA-IM. Rev Esp Cardiol. 2014;67:999-1006.

74. González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Palomo J, Delgado J, Roig E, Lage E, Manito N; Spanish Heart Transplantation Teams.Spanish Heart Transplantation Registry. 25th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013). Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):1039-51.

CONTINÚA EN SIGUIENTE PÁGINA

(9)

75. González-Vílchez F, Vázquez de Prada JA. Chronic renal insufficiency in heart transplant recipients: risk factors and management options. Drugs. 2014 Sep;74(13):1481-94. doi: 10.1007/s40265-014-0274-9. Review.

76. Crespo-Leiro MG, Delgado-Jiménez J, López L, Alonso-Pulpón L, González-Vilchez F, Almenar-Bonet L, Rábago G, Pérez-Villa F, Paniagua Martín MJ, Arizón Del Prado JM, Sousa-Casasnovas I, Manito-Lorite N, Díaz-Molina B, Pascual-Figal D, Lage-Galle E, Blasco-Peiró T, De la Fuente-Galán L, Muñiz J. The falling incidence of hematologic cancer after heart transplantation. Clin Transplant. 2014 Oct;28(10):1142-7.

77. Barge-Caballero E, Almenar-Bonet L, Villa-Arranz A, Pérez-Villa F, Segovia-Cubero J, Delgado-Jiménez J, González-Vilchez F, Manito-Lorite N, De-la-Fuente-Galán L, Brossa-Loidi V, Lambert-Rodríguez JL, Pascual-Figal D, Lage-Gallé E, Arizón-Del-Prado JM, Sanz-Julve M, Muñiz-García J, Crespo-Leiro M. Impact of short-term mechanical circulatory support with extracorporeal devices on postoperative outcomes after emergency heart transplantation: data from a multi-institutional Spanish cohort. Int J Cardiol. 2014 Sep;176(1):86-93.

78. González-Vílchez F, Arizón JM, Segovia J, Almenar L, Crespo-Leiro MG, Palomo J, Delgado JF, Mirabet S, Rábago G, Pérez-Villa F, Díaz B, Sanz ML, Pascual D, de la Fuente L, Guinea G; ICEBERG Study Group. Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study. Transplant Proc. 2014 Jan-Feb;46(1):14- 20.

79. Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?. Int J Cardiol. 2014 Jan 15;171(1):15-23.

80. Arnáiz-García ME, Gutiérrez-Diez F, Arnáiz-García AM, Arnáiz J, Expósito V, Nistal JF, Rodríquez-Entem F, Olalla JJ, López-Rodríguez J, González-Santos JM. Successful retrieval of an irretrievable jugular tesio catheter using a fogarty arterial embolectomy catheter. Vasc Endovascular Surg. 2014 May;48(4):349-51.

81. De Belder A, de la Torre Hernandez JM, Lopez-Palop R, O'Kane P, Hernandez F, Strange J, Gimeno F, Cotton J, Diaz Fernandez J, Carrillo Saez P, Thomas M, Pinar E, Curzen N, Baz J, Cooter N, Lozano I, Skipper N, Robinson D, Hildick-Smith D. A Prospective Randomized Trial Of Everolimus-Eluting Stents Versus Bare Metal Stents In Octogenarians: Xience Or Vision Stents For The Management Of Angina In The Elderly - The Xima Trial. J Am Coll Cardiol. 2014; 63: 1371-5.

82. Jose M de la Torre Hernandez, José Antonio Baz Alonso, Joan Antoni Gómez Hospital, Fernando Alfonso, Tamara Garcia Camarero, Federico Gimeno de Carlos, Gerard Roura Ferrer, Angel Sanchez Recalde, Íñigo Lozano Martínez-Luengas, Josep Gomez Lara, Felipe Hernandez, María José Pérez-Vizcayno, Angel Cequier Fillat, Armando Perez de Prado, Agustín Albarrán, Manuel Jimenez Navarro, Josepa Mauri, Jose A Fernandez Diaz, Eduardo Pinar, Javier Zueco. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: patient level pooled analysis of 4 registries. J Am Coll Cardiol Intv. 2014;7:244-54.

83. Valgimigli M, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Ferrante G. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ. 2014 Nov 4;349:g6427.

(10)

84. Dominguez-Rodriguez A, Abreu-Gonzalez P, Del Mar Garcia-Saiz M, Aldea-Perona A, de la Torre JM, Garcia-Camarero T, Consuegra-Sanchez L; on behalf of the MARIA Study Investigators. Cardioprotection with melatonin in the acute myocardial infarction:

Awaiting results of MARIA trial ?. Int J Cardiol. 2014 Dec 30;182C:54-55.

85. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Response to letter regarding article,

"effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".

Circulation. 2014 Jul 15;130(3):e19-20.

86. De la Torre Hernandez JM, Masotti Centol M, Lerena Saenz P, Sánchez Recalde A, Gimeno de Carlos F, Piñón Esteban P, Fernandez Rodriguez D, Sitges Carreño M, Sabate Tenas M, Zueco Gil J. Eficacia y seguridad a más de 10 años de la ablación septal percutánea en la miocardiopatía hipertrófica obstructiva. Rev Esp Cardiol.

2014;67:353-8.

87. De la Torre Hernández JM, Alfonso F, Martin Yuste V, Sánchez Recalde A, Jiménez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, García Camarero T, Elizaga J, Calviño R, Moreu J, Bosa F, Jimenez Mazuecos J, Ruiz-Arroyo JR, García Del Blanco B, Rumoroso JR; en representación del grupo de estudio ESTROFA-IM. Comparacion de stents de Paclitaxol y stents de everolimus enel infartocon elevaciond el ST e influencia de la trombectomia en los resultados. Estudio ESTROFA-IM. Rev Esp Cardiol. 2014;67:999-1006.

88. Delgado JF, Oliva J, Llano M, Pascual-Figal D, Grillo JJ, Comín-Colet J, Díaz B, Martínez de La Concha L, Martí B, Peña LM. Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain. Rev Esp Cardiol (Engl Ed). 2014 Aug;67(8):643-50.

89. Pajarón M, Fernández-Miera MF, Allende I, Arnaiz AM, Gutierrez-Cuadra M, Cobo- Belaustegui M, Armiñanzas C, de Berrazueta JR, Fariñas MC, Sanroma P, Hospital Valdecilla Endocarditis Study Group. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) or infective endocarditis: a safe and effective model. Eur J Intern Med. 2015 Mar;26(2):131-6.

90. de la Torre Hernández JM, Hernández F, Alfonso F. The optimal cutoff value for left main minimal lumen area of 4.5 mm(2): a word of caution. JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):122-3.

91. Ruiz-Salas A, Barrera-Cordero A, Viñolas X, Sola NB, Álvarez LP, Olalla JJ, Brugada J, Alzueta Usefulness of antitachycardia pacing in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Int J Cardiol. 2015 Feb 15;181:172-3.

92. de la Torre Hernández JM, Moreno R, Lee DH, Garcia Del Blanco B, San Martin JC, Serra Garcia V, Gaviria K, Garcia Blas S, Garcia I, Zueco J. The routine use of a surgical exposure approach for trans-femoral implantation of the balloon expandable aortic prosthesis is associated to a low rate of vascular complications. Results from a multicenter registry. J Cardiovasc Surg (Torino). 2015 Feb 12. Epub ahead of print.

(11)

93. de la Torre Hernandez JM, Lee DH, Garcia Camarero T, Sainz Laso F, Toranzo I, Goicolea L, Zueco J. Two-month healing evaluation of an everolimus Pt-Cr DES with erodible polymer and two bioresorbable scaffolds implanted in the same vessel of the same patient. EuroIntervention. 2015 Apr 22;10(12):e1-2.

94. Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García Del Blanco B, García-Touchard A, López-Minguéz JR, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernández-Ortíz A, Escaned J, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C; Restenosis Intra-stent: drug-eluting Balloon vs. everolimus-eluting Stent (RIBS IV) Study Investigators (under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology).Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug- eluting stent restenosis). EuroIntervention. 2015 Jul;11(3):336-42.

95. Martin-Reyes R, de la Torre Hernandez JM, Franco-Pelaez J, Lopez-Palop R, Telleria Arrieta M, Amat Santos IJ, Carrillo Saez P, Sanchez-Recalde A, Sanmartin Pena JC, Garcia Camarero T, Brugaletta S, Gimeno de Carlos F, Pinero A, Sorto Sanchez DC, Frutos A, Lasa Larraya G, Navarro F, Farre J. The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study. Catheter Cardiovasc Interv. 2015 Jul 25. [Epub ahead of print].

96. de la Torre Hernández JM, Tejedor P, Camarero TG, Duran JM, Lee DH, Monedero J, Laso FS, Calderón MA, Veiga G, Zueco J. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation. Catheter Cardiovasc Interv. 2015 Nov 3. [Epub ahead of print].

97. Lozano I, Serrador A, Lopez-Palop R, Lasa G, Moreu J, Pinar E, de Prado AP, Alfonso F, Jimenez NM, Quero MF, Pineda J, Martin MJ, Garcia SR, Lopez M, Jr., Suarez CA, Gutierrez A, Hernandez F, Baz JA, Benedicto A, Rumoroso JR, Gomez-Hospital JA, Serra V, de la Torre JM, Ruiz-Quevedo V, Botas J, Fernandez JA, Sanchez-Recalde A.

Immediate and Long-Term Results of Drug-Eluting Stents in Mammary Artery Grafts. Am J Cardiol 2015; 116:1695-1699.

98. Jose M de la Torre Hernandez, Tamara Garcia Camarero. Intravascular ultrasound for the diagnosis and treatment of left main coronary artery disease. Interventional Cardiology Clinics. Suppl.: Intravascular imaging: OCT and IVUS. July 2015; Vol. 4 Num 3: 361-382.

99. de la Torre Hernandez JM. Balloon-expandable vs. self-expanding stents: new insights into a renewed debate. EuroIntervention. 2015 Dec 22;11(8):852-4.

100. Lozano I, Sanchez-Insa E, de Leiras SR, Carrillo P, Ruiz-Quevedo V, Pinar E, Gopar- Gopar S, Bayon J, Mañas P, Lasa G, CruzGonzalez I, Hernandez F, Fernandez-Portales J, Fernandez-Fernandez J, Pérez-Serradilla A, de la Torre Hernandez JM, Gomez- Jaume A. Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel. Am J Cardiol. 2015 Nov 18 [Epub ahead of print].

CONTINÚA EN SIGUIENTE PÁGINA

(12)

101. Moretti C, Chandran S, Vervueren PL, D'Ascenzo F, Barbanti M, Weerackody R, Boccuzzi G, Lee DH, de la Torre Hernandez J, Omedè P, Nijenhuis V, Igbineweka N, Lim P, Berg T, Carriè D, Hildick-Smith D, Gulino S, Cannata S, Gargiulo G, Tamburino C, Conrotto F, Meynet I, Quadri G, Marangoni L, Taha S, Biondi-Zoccai G, Salizzoni S, Marra S, Gaita F. Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry. J Invasive Cardiol. 2015 Dec;27(12):547-53.

102. Martinez-Selles M, Almenar L, Paniagua-Martin MJ, Segovia J, Delgado JF, Arizón JM, Ayesta A, Lage E, Brossa V, Manito N, Pérez-Villa F, Diaz-Molina B, Rábago G, Blasco- Peiró T, De La Fuente Galán L, Pascual-Figal D, Gonzalez-Vilchez F; Spanish Registry of Heart Transplantation. Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry. Transpl Int. 2015 Mar;28(3):305-13.

103. Barge-Caballero E, Segovia-Cubero J, González-Vilchez F, Delgado-Jiménez J, Pérez- Villa F, Almenar-Bonet L, Arizón-Del Prado JL, Lage-Gallé E, De La Fuente-Galán L, Manito-Lorite N, Sanz-Julve M, Villa-Arranz A, Lambert Rodríguez JL, Brossa-Loidi V, Pascual-Figal D, Muñiz-García J, Crespo-Leiro M. Evaluation of the preoperative vasoactive-inotropic score as a predictor of postoperative outcomes in patients undergoing heart transplantation.Int J Cardiol. 2015 Apr 15;185:192-4.

104. Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, García-Touchard A, López-Minguéz JR, Benedicto A, Masotti M, Zueco J, Iñiguez A, Velázquez M, Moreno R, Mainar V, Domínguez A, Pomar F, Melgares R, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C; RIBS IV Study Investigators (under auspices of Interventional Cardiology Working Group of Spanish Society of Cardiology) A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial..J Am Coll Cardiol. 2015 Jul 7;66(1):23-33.

105. Delgado JF, Almenar L, González-Vilchez F, Arizón JM, Gómez M, Fuente L, Brossa V, Fernández J, Díaz B, Pascual D, Lage E, Sanz M, Manito N, Crespo-Leiro MG.Health- related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross-sectional study. Clin Transplant.

2015 Sep; 29(9):771-80.

106. Delgado JF, Alonso-Pulpón L, Mirabet S, Almenar L, Pérez Villa F, González-Vílchez F, Palomo J, Blasco T, García-Cosio MD, González-Costello J, de la Fuente L, Rábago G, Lage E, Pascual D, Díaz Molina B, Arizón JM, Muñiz J, Crespo-Leiro MG. Cancer incidence in heart transplant recipients with previous neoplasia history. Am J Transplant.

2015 Nov 27 [Epub ahead of print].

107. Expósito V, Rodríguez-Mañero M, González-Enríquez S, Arias MA, Sánchez-Gómez JM, Andrés La Huerta A, Bertomeu-González V, Arce-León Á, Barrio-López MT, Arguedas-Jiménez H, Seara JG, Rodriguez-Entem F. Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: results of a Spanish multicentre study. Europace. 2015 Nov 12. [Epub ahead of print].

108. Manito N, Delgado JF, Crespo-Leiro MG, Arizón JM, Segovia J, González-Vílchez F, Mirabet S, Lage E, Pascual-Figal D, Díaz B, Palomo J, Rábago G, Sanz M, Blasco T, Roig E. Twelve-monthefficacy and safety of the conversion to everolimus in maintenance heart transplant recipients. World J Transplant. 2015 Dec 24;5(4):310-9.

CONTINÚA EN SIGUIENTE PÁGINA

(13)

109. Expósito V, Seras M, Fernández-Fresnedo G [Oral anticoagulation in chronic kidney disease with atrial fibrillation]. Med Clin (Barc). 2015 May 21;144(10):452-6.

110. de la Torre Hernández JM, Oteo Domínguez JF, Hernández F, García Camarero T, Abdul-Jawad Altisent O, Rivero Crespo F, Cascón JD, Zavala G, Gimeno F, Arrebola Moreno AL, Andraka L, Gómez Menchero A, Bosa F, Carrillo X, Sánchez Recalde Á, Alfonso F, Pérez de Prado A, López Palop R, Sanchis J, Diarte de Miguel JA, Jiménez Navarro M, Muñoz L, Ramírez Moreno A, Tizón Marcos H; ESTROFA-DAPT and ESTROFA-2 study groups. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2. Rev Esp Cardiol (Engl Ed). 2015 Jun 10. [Epub ahead of print].

111. Hernández Hernández F, de la Torre Hernández JM, Rumoroso Cuevas JR, García del Blanco B, Martínez-Sellés M, Trillo Nouche R.2014 update on interventional cardiology.Rev Esp Cardiol (Engl Ed). 2015 Apr;68(4):324-30.

112. Lozano I, Gomez-Jaume A, Torre Hernandez JM, Perez SA, Fernandez FJ, Fernandez'- Portales J. Use of the New Antiplatelet Agents in Acute Coronary Syndromes:

Limitations Related to Patient Characteristics. Rev Esp Cardiol (Engl Ed) 2015;

68(5):448-450.

113. González-Vílchez F, Segovia Cubero J, Almenar L, Crespo-Leiro MG, Arizón JM, Villa A, Delgado J, Roig E, Lage E, González-Costello J; Spanish Heart Transplantation Teams.

Spanish Heart Transplantation Registry. 26th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2014). Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):1008-21.

114. Manejo actual de la fibrilación auricular. Toranzo I, Olavarri I, Expósito V, Gutiérrez- Morlote J. Revista Médica Valdecilla. 2015:0 (0). ISSN 2444-3840.

115. Lacunza-Ruiz FJ, Moya-Mitjans A, Martínez-Alday J, Barón-Esquivias G, Ruiz-Granell R, Rivas-Gándara N, González-Enríquez S, Leal-del-Ojo J, García-Heil N, García-Alberola A. Differences in the yield of the implantable loop recorder between secondary and tertiary centers. Cardiol J. 2015;22(3):241-6.

116. Ruiz-Salas A1, Barrera-Cordero A2, Viñolas X3, Sola NB4, Álvarez LP5, Olalla JJ6, Brugada J7, Alzueta J2. Usefulness of antitachycardia pacing in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Int J Cardiol. 2015 Feb 15;181:172-3.

Referencias

Documento similar

(Boix-Sau«et.al.», 2021) Urien-Pérez M a Z, Velayos-Velayos A, Galán-Martín N y García- García M a ZB (2017)realizaron una revisión de la literatura existente

Només els documents contractuals, definits a l’apartat anterior, constitueixen la base del contracte; per tant, el contractista no podrà al·legar cap modificació de les condicions

Como Coopeuch renovamos nuestro compromiso con mejorar la calidad de vida de todos nuestros socios, tratando siempre de aportar al desarrollo de Chile y continuaremos mostrando

◗ La actividad principal de CITANDALUCÍA es la promoción de PYMEs innovadoras por la explotación de las oportunidades del sistema de intercambio de resultados de

TATIVA DEL TRIBUNAL EUROPEO DE DERECHOS HUMANOS EN LA SENTENCIA DE 13 DE JULIO DE 2004.1. La evolución jurispruden- cial en la interpretación de los arts. A) El derecho al respeto de

De manera preliminar y durante el proceso exploratorio en la elección del tema problema para este trabajo de profundización, se observó que dentro de las prácticas de

Internacional son una referencia para los profesionales y empresas de tecnología y comercio de frutas, hortalizas, flores y viveros en todo el mundo.. QCj es la revista

De esta forma la política del horror abrió el paso a una nueva era, pues el sistema anár- quico de islas absolutas, con la exclusividad del uso de la fuerza interna y externa y con